ResearcherGdańsk Medical UniversityActive in the last 2 years
Iwona Inkielewicz‐Stępniak
Matched on ORCID iD 0000-0003-1676-2723; OpenAlex author ID A5108166976. Sources: OpenAlex.
Their work
- Papers
- 11 (first author 5, last author 6)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 8
2017: 1 paper · 2018: 2 papers · 2019: 1 paper · 2020: none · 2021: 2 papers · 2022: none · 2023: none · 2024: 2 papers · 2025: none · 2026: 3 papers
Papers 11
- Epigenetic Regulators as Therapeutic Targets in Pancreatic Ductal Adenocarcinoma. First author DOI 10.3390/cancers18061001↗
- Correction: Kubiak, K.; Inkielewicz-Stępniak, I. Epigenetic Regulators as Therapeutic Targets in Pancreatic Ductal Adenocarcinoma. Cancers 2026, 18, 1001. First author DOI 10.3390/cancers18132108↗
- Pancreatic cancer-associated myofibroblasts: a review. First author DOI 10.7150/ijbs.121234↗
- Graphene Oxide Nanoparticles and Organoids: A Prospective Advanced Model for Pancreatic Cancer Research. First author DOI 10.3390/ijms25021066↗
- Design, Synthesis, and Antitumor Evaluation of an Opioid Growth Factor Bioconjugate Targeting Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/pharmaceutics16020283↗
- Oxidovanadium(IV) Complex Disrupts Mitochondrial Membrane Potential and Induces Apoptosis in Pancreatic Cancer Cells. Last author DOI 10.2174/1871520620666200624145217↗
- Pancreatic Cancer and Platelets Crosstalk: A Potential Biomarker and Target. First author DOI 10.3389/fcell.2021.749689↗
- New Oxidovanadium(IV) Coordination Complex Containing 2-Methylnitrilotriacetate Ligands Induces Cell Cycle Arrest and Autophagy in Human Pancreatic Ductal Aden… Last author DOI 10.3390/ijms20020261↗
- Role of Oxidative and Nitro-Oxidative Damage in Silver Nanoparticles Cytotoxic Effect against Human Pancreatic Ductal Adenocarcinoma Cells. Last author DOI 10.1155/2018/8251961↗
- Silver nanoparticles of different sizes induce a mixed type of programmed cell death in human pancreatic ductal adenocarcinoma. Last author DOI 10.18632/oncotarget.22563↗
- Selective cytotoxicity of vanadium complexes on human pancreatic ductal adenocarcinoma cell line by inducing necroptosis, apoptosis and mitotic catastrophe pro… Last author DOI 10.18632/oncotarget.19454↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Klaudia Kubiak · 2 shared papers, 2026 · strength 1.26
- Shaoshan Mai · 3 shared papers, 2021–2024 · strength 0.95
- Paper Graphene Oxide Nanoparticles and Organoids: A Prospective Advanced Model for Pancreatic Cancer Research. DOI 10.3390/ijms25021066↗
- Paper Pancreatic Cancer and Platelets Crosstalk: A Potential Biomarker and Target. DOI 10.3389/fcell.2021.749689↗
- Paper Design, Synthesis, and Antitumor Evaluation of an Opioid Growth Factor Bioconjugate Targeting Pancreatic Ductal Adenoca… DOI 10.3390/pharmaceutics16020283↗
- Marcin Banacki · 1 shared paper, 2026 · strength 0.63
- Stanisław Hać · 3 shared papers, 2017–2024 · strength 0.42
- Paper Design, Synthesis, and Antitumor Evaluation of an Opioid Growth Factor Bioconjugate Targeting Pancreatic Ductal Adenoca… DOI 10.3390/pharmaceutics16020283↗
- Paper New Oxidovanadium(IV) Coordination Complex Containing 2-Methylnitrilotriacetate Ligands Induces Cell Cycle Arrest and A… DOI 10.3390/ijms20020261↗
- Paper Selective cytotoxicity of vanadium complexes on human pancreatic ductal adenocarcinoma cell line by inducing necroptosi… DOI 10.18632/oncotarget.19454↗
- Szymon Kowalski · 3 shared papers, 2017–2021 · strength 0.39
- Paper Oxidovanadium(IV) Complex Disrupts Mitochondrial Membrane Potential and Induces Apoptosis in Pancreatic Cancer Cells. DOI 10.2174/1871520620666200624145217↗
- Paper New Oxidovanadium(IV) Coordination Complex Containing 2-Methylnitrilotriacetate Ligands Induces Cell Cycle Arrest and A… DOI 10.3390/ijms20020261↗
- Paper Selective cytotoxicity of vanadium complexes on human pancreatic ductal adenocarcinoma cell line by inducing necroptosi… DOI 10.18632/oncotarget.19454↗
- Justyna Budka · 1 shared paper, 2024 · strength 0.22
- Ewelina Zielinska · 1 shared paper, 2018 · strength 0.12
- Ewelina Barcińska · 1 shared paper, 2018 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.